IF YOU HAVE COPD, YOU SHOULD GET SCREENED FOR ALPHA-1.
The AlphaID™ At Home Genetic Health Risk Service detects your risk for genetic COPD, a condition called alpha-1 antitrypsin deficiency (AATD), or alpha-1.
See how easy it is to discover your risk for alpha-1.
With AlphaID™ At Home, you simply collect a small saliva sample by swabbing along your gumline. Ready to discover your risk for alpha-1? Watch an overview of the process in this quick video.
Along the way, we'll provide helpful updates. Don’t wait another day to learn your risk for alpha-1. Start by taking the first step to learning your risk: Order your free at-home screening kit today.
Your privacy is protected.
The AlphaID At Home Genetic Health Risk Service is FDA cleared and HIPAA compliant. The site is secure and confidential. Your report is only accessible by you, on the website, using the password you create when registering.
Take a look inside.
What’s included with the AlphaID™ At Home Saliva Collection Kit? Watch this brief video to peek inside.
If you learn you’re at risk, talk with your healthcare provider.
Only a healthcare professional can diagnose alpha-1, so regardless of your risk, be sure to share your results with them. If you are diagnosed with alpha-1, there may be FDA-approved treatment options to consider with your healthcare provider.† Download a free discussion guide to help start the conversation.
Want to know more about genetic COPD screening?
Sign up to learn more about the free AlphaID At Home Service. We’ll show you how easily AlphaID At Home can help you learn your risk for genetic COPD.
*The AlphaID At Home Genetic Health Risk Service, including the kit, is provided for free and may not be billed to patients or their insurers. There is no obligation to purchase or use any product or service offered by any manufacturer.
†Talk to your healthcare provider about possible treatment options.
References
- American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003 Oct 1;168(7):818-900.
- Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Pulmonary Disease. GOLD COPD 2021 report.
- Sandhaus RA, Turino G, Brantly ML, Campos M, Cross CE, Goodman K, Hogarth DK, Knight SL, Stocks JM, Stoller JK, Strange C, Teckman J. The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult. Chronic Obstr Pulm Dis. 2016 Jun 6;3(3):668-682.
- World Health Organization. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Org. 1997;75(5):397-415.